SCHEMBL3208722

SCHEMBL3208722

O=C(Nc1ccc(C(=O)O)c(O)c1)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.67
KMT2A Q03164 4/20 0.50
PKM P14618 1/20 0.50
CASP3 P42574 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPK1 P28482 1/20 0.49
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.49
SENP8 Q96LD8 1/20 0.49
HSD17B10 Q99714 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
FABP7 O15540 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL595196 0.91 EPHX2 (0.67) EPHX2KMT2ACASP3CYP1A2CYP2D6
SCHEMBL2648379 0.88 EPHX2 (0.64) EPHX2KMT2ACASP3CYP1A2CYP2D6
SCHEMBL3581504 0.84 EPHX2 (0.58) EPHX2KMT2ACASP3MAPK1RAB9A
SCHEMBL569486 0.83 EPHX2 (0.60) EPHX2KMT2ACASP3ALDH1A1FABP5
SCHEMBL15711868 0.82 EPHX2 (0.65) EPHX2KMT2ACASP3CYP1A2CYP2D6
SCHEMBL8366872 0.82 EPHX2 (0.75) EPHX2KMT2ACASP3RAB9AALDH1A1
SCHEMBL29561956 0.81 EPHX2 (0.63) EPHX2KMT2ACASP3ALDH1A1FABP7
SCHEMBL118052 0.81 EPHX2 (0.63) EPHX2KMT2ACASP3ALDH1A1FABP7
SCHEMBL29401210 0.81 EPHX2 (0.63) EPHX2KMT2ACASP3ALDH1A1FABP7
SCHEMBL17151439 0.81 EPHX2 (0.74) EPHX2KMT2ACASP3FABP7FABP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682123-B2 Methods of treating metabolic disease THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2017-06-20 US disclosed
US-20150190466-A1 METHODS OF TREATING METABOLIC DISEASE NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-07-09 US disclosed
US-20130160150-A1 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2013-06-20 US disclosed
US-8460880-B2 Compositions, splice variants and methods relating to ovarian specific genes and proteins DIADEXUS, INC. (US) 2013-06-11 US disclosed
US-7678889-B2 Compositions and methods relating to ovarian specific genes and proteins DIADEXUS, INC. (US) 2010-03-16 US disclosed
US-20090263411-A1 Compositions, splice variants and methods relating to ovarian specific genes and proteins DIAZYME LABORATORIES, INC. 2009-10-22 US disclosed
WO-2009076651-A9 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-08-27 WO disclosed
WO-2009076651-A2 METHODS FOR IDENTIFYING COMPOUNDS THAT MODULATE LISCH-LIKE PROTEIN OR C1ORF32 PROTEIN ACTIVITY AND METHODS OF USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-06-18 WO disclosed
US-20090118175-A1 Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer MACINA ROBERTO A 2009-05-07 US disclosed
US-20080260761-A1 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins DIADEXUS, INC. 2008-10-23 US disclosed
WO-2002039431-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-16 WO disclosed
WO-2002036807-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036616-A2 COMPOSITIONS AND METHODS RELATING TO BREAST SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
WO-2002036808-A2 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-05-10 WO disclosed
US-20020048763-A1 Human genome-derived single exon nucleic acid probes useful for gene expression analysis AMERSHAM PLC (GB) 2002-04-25 US disclosed
US-20020048800-A1 Myosin-like gene expressed in human heart and muscle GE HEALTHCARE LIMITED (GB) 2002-04-25 US disclosed
WO-2002026818-A2 HUMAN NEDD-1 AEOMICA, INT. (US) 2002-04-04 WO disclosed
WO-2002024718-A1 COMPOSITIONS AND METHODS RELATING TO PROSTATE SPECIFIC GENES AND PROTEINS DIADEXUS, INC. (US) 2002-03-28 WO disclosed
WO-2002024750-A2 HUMAN KIDNEY TUMOR OVEREXPRESSED MEMBRANE PROTEIN 1 AEOMICA, INC. (US) 2002-03-28 WO disclosed
WO-2001092524-A2 MYOSIN-LIKE GENE EXPRESSED IN HUMAN HEART AND MUSCLE AEOMICA, INC. (US) 2001-12-06 WO disclosed